At our first Capital Markets Day, our team shared a detailed presentation on Mentice's business, products, market trends, and strategy. You'll learn why our solutions are highly valued by physicians, and how we're leading innovators in simulation training. Also, we've updated our financial targets, which will be discussed.
At our first Capital Markets Day, our team shared a detailed presentation on Mentice's business, products, market trends, and strategy. You'll learn why our solutions are highly valued by physicians, and how we're leading innovators in simulation training. Also, we've updated our financial targets, which will be discussed.
At our first Capital Markets Day, our team shared a detailed presentation on Mentice's business, products, market trends, and strategy. You'll learn why our solutions are highly valued by physicians, and how we're leading innovators in simulation training. Also, we've updated our financial targets, which will be discussed.
VD Göran Malmberg och aktieanalytiker RIkard Engberg diskutera ett av bolagets starkaste kvartal sedan börsnoteringen. Bolagets ökade lönsamhet och tillväxt i återkommande intäkter diskuteras i detalj.
Aktieanalytiker Peter Sellei intervjuar Mentices VD Göran Malmberg om det senaste kvartalet Q4`22 samt hur bolaget ser på utvecklingen den närmaste tiden
VD Göran Malmberg och aktieanalytiker RIkard Engberg diskutera ett av bolagets starkaste kvartal sedan börsnoteringen. Bolagets ökade lönsamhet och tillväxt i återkommande intäkter diskuteras i detalj.
Aktieanalytiker Peter Sellei intervjuar Mentices VD Göran Malmberg om det senaste kvartalet Q4`22 samt hur bolaget ser på utvecklingen den närmaste tiden
